Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
23 /100
LOW RISK
Score updated Aug 28, 2026

NUS — Nu Skin Enterprises, Inc. Dilution Risk Tracker

Track NUS dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track NUS — Get alerts when the score changes →

As of August 28, 2026, Nu Skin Enterprises, Inc. (NUS) has a DilutionWatch DilutionScore of 23/100, rated LOW dilution risk. Nu Skin Enterprises, Inc. has a market capitalization of $281.11M, 48.68M shares outstanding, 179 institutional holders tracked.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
39
💰 Cash Runway
0
📊 Float Risk
10
⚠️ Warrant Exposure
40
🔄 Convertible Debt
40

Dilution Forecast

☀️
Clear
No significant dilution signals
model est. 0%
No significant dilution signals detected for NUS.
🔔 Track NUS — Get forecast alerts →

Market Data

Market Cap$281.11M
Shares Outstanding48.68M
Float47.35M
Cash$191.39M
Debt$213.66M
Short InterestN/A

Institutional Holdings

QoQ: ↑ 13.2% shares (2026Q1 vs prior)
179 institutional holders · 42.59M shares
#1 BlackRock, Inc. 4.29M shares
#2 VANGUARD CAPITAL MANAGEMENT LLC 4.13M shares
#3 MORGAN STANLEY 3.20M shares
+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest4.63M
Days to Cover10.0
% of Float9.8%
FINRA data as of Jul 31, 2026

Recent SEC Activity

xbrl XBRL CONVERTIBLE 2018-12-31
Full SEC filing analysis available with free account →

Recent News

No recent news

Factual NUS Dilution Snapshot

Nu Skin Enterprises, Inc. (NUS) has a DilutionScore of 23/100, rated Low dilution risk. Score date: August 28, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

Track NUS Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking NUS — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

Related Stocks — LOW Risk

Other LOW dilution risk stocks tracked by DilutionWatch with similar profiles:

HON AIG APTV BABAF CMCSA CPT DBD EE GM GTX

Browse all 8,024+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for NUS
NUS FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.